BioTrack Capital is a venture capital firm founded in 2017 and based in Shanghai, China. The firm focuses on investing in and incubating early-stage biotech, medtech, and healthcare companies across China.
30% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (2 deals in the last 12 months vs 3 prior). Their most common stage is series-a (52% of deals). Average disclosed round size is $157.4M (across 26 rounds with reported amounts).
Portfolio
29
Fund Size
$250M
Top Stage
Series A
Last 12 Mo
2
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
40 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| AAureka | Series A | — | Apr 2026 |
| SSyneron Bio | Series B | $150M | Mar 2026 |
| AAureka | Series A | $35M | Jan 2026 |
 BlossomHill Therapeutics | Series B | $84M | Dec 2025 |
 Rapafusyn | Series A | $44M | Sep 2025 |
| MMinghui Pharmaceutical | Ipo | $131M | Aug 2025 |
| PPAQ Therapeutics | Series B | $39M | May 2025 |
| Rapafusyn | Series A | $44M | Jan 2025 |
 Rona Therapeutics | Series A | $35M | Jul 2024 |
 Rona | Series A | $35M | Jul 2024 |
 Brise Pharmaceuticals | Series A | $20M | Apr 2024 |
| OOnCusp Therapeutics | Series A | $100M | Jan 2024 |
 OnCusp | Series A | $100M | Jan 2024 |
| Rona | Series A | $200M | Jan 2024 |
 Sirius Therapeutics | Series B | $50M | Oct 2023 |
 Pyrotech | Series A | — | Jul 2023 |
| PPyrotech Therapeutics | Series A | — | Jul 2023 |
| OOnCusp Therapeutics | Seed | — | Aug 2022 |
| AAstraBio | Series A | — | Jun 2022 |
| Rona Therapeutics | Series A | $33M | Apr 2022 |
| CCarcell Biopharma | Unknown | — | Nov 2021 |
| HHC Scientific | Series B | — | Sep 2021 |
| AAbogen | Series C | $700M | Aug 2021 |
| AAbogen Biosciences | Series C | $700M | Aug 2021 |
 Exegenesis Bio | Series B | $50M | Jun 2021 |
Page 1 of 2
Top Co-Investors
LAV11 shared
Legend Capital8 shared
OrbiMed8 shared
5Y Capital6 shared
FreeS Fund4 shared
LYFE Capital4 shared
Fidelity Investments3 shared
Sherpa Healthcare Partners3 shared
GL Ventures3 shared
Sinovation Ventures3 shared
Loyal Valley Capital3 shared
IDG Capital3 shared
F-Prime Capital3 shared
3E Bioventures Capital3 shared
LongRiver Investments3 shared
K2VC3 shared
Lake Bleu Capital3 shared
Northern Light Venture Capital3 shared
Guotai Junan International3 shared
Last updated: 20 October 2026